Barker RA

References (4)

Title : Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study - Nombela_2014_Brain_137_2743
Author(s) : Nombela C , Rowe JB , Winder-Rhodes SE , Hampshire A , Owen AM , Breen DP , Duncan GW , Khoo TK , Yarnall AJ , Firbank MJ , Chinnery PF , Robbins TW , O'Brien JT , Brooks DJ , Burn DJ , Barker RA
Ref : Brain , 137 :2743 , 2014
Abstract : Nombela_2014_Brain_137_2743
ESTHER : Nombela_2014_Brain_137_2743
PubMedSearch : Nombela_2014_Brain_137_2743
PubMedID: 25080285

Title : Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis - Kehagia_2013_Neurodegener.Dis_11_79
Author(s) : Kehagia AA , Barker RA , Robbins TW
Ref : Neurodegener Dis , 11 :79 , 2013
Abstract : Kehagia_2013_Neurodegener.Dis_11_79
ESTHER : Kehagia_2013_Neurodegener.Dis_11_79
PubMedSearch : Kehagia_2013_Neurodegener.Dis_11_79
PubMedID: 23038420

Title : Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease - Kehagia_2010_Lancet.Neurol_9_1200
Author(s) : Kehagia AA , Barker RA , Robbins TW
Ref : Lancet Neurol , 9 :1200 , 2010
Abstract : Kehagia_2010_Lancet.Neurol_9_1200
ESTHER : Kehagia_2010_Lancet.Neurol_9_1200
PubMedSearch : Kehagia_2010_Lancet.Neurol_9_1200
PubMedID: 20880750

Title : Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options - Williams-Gray_2006_CNS.Drugs_20_477
Author(s) : Williams-Gray CH , Foltynie T , Lewis SJ , Barker RA
Ref : CNS Drugs , 20 :477 , 2006
Abstract : Williams-Gray_2006_CNS.Drugs_20_477
ESTHER : Williams-Gray_2006_CNS.Drugs_20_477
PubMedSearch : Williams-Gray_2006_CNS.Drugs_20_477
PubMedID: 16734499